<p><a href="https://www.yakup.com/news/index.html?mode=view&pmode=&cat=12&cat2=121&cat3=&nid=328430&num_start=0" target="_blank" class="ke-link">https://www.yakup.com/news/index.html?mode=view&pmode=&cat=12&cat2=121&cat3=&nid=328430&num_start=0</a></p><div class="figure-open" contenteditable="false" data-ke-type="opengraph" data-ke-align="alignCenter" data-og-type="website" data-og-title="[약업신문]한독, ‘엠파벨리주 인젝터’ 국내 도입… PNH 치료 지속성 고려 투여 옵션 확대" data-og-description="한독(대표이사 김영진, 백진기)이 5월 28일 발작성 야간 혈색소뇨증(Paroxysmal Nocturnal Hemoglobinuria, 이하 PNH) 치료제 엠파벨리주(pegcetacoplan)에 적용되는 인젝터의 첫 투약을 기준으로 국내 공급을 시." data-og-host="www.yakup.com" data-og-source-url="https://www.yakup.com/news/index.html?mode=view&pmode=&cat=12&cat2=121&cat3=&nid=328430&num_start=0" data-og-url="https://www.yakup.com/news/index.html?cat=12&cat2=121&cat3=&mode=view&nid=328430&num_start=0&pmode=" data-og-image="https://scrap.kakaocdn.net/dn/ddu77b/dJMb8PGERF5/OSyjLDeEFphtJVNLcNt1Y1/img.jpg?width=975&height=981&face=0_0_975_981"><a href="https://www.yakup.com/news/index.html?mode=view&pmode=&cat=12&cat2=121&cat3=&nid=328430&num_start=0" target="_blank" data-source-url="https://www.yakup.com/news/index.html?mode=view&pmode=&cat=12&cat2=121&cat3=&nid=328430&num_start=0"><div class="og-image"><img class="thumb_img" src="https://scrap.kakaocdn.net/dn/ddu77b/dJMb8PGERF5/OSyjLDeEFphtJVNLcNt1Y1/img.jpg?width=975&height=981&face=0_0_975_981" alt="" xxonerror="this.src="//img1.kakaocdn.net/thumb/C200x200/?fname=https%3A%2F%2Ft1.daumcdn.net%2Fcafe_image%2Fcafe_meta_image_190529.png""></div><div class="og-text"><p class="og-title">[약업신문]한독, ‘엠파벨리주 인젝터’ 국내 도입… PNH 치료 지속성 고려 투여 옵션 확대</p><p class="og-desc">한독(대표이사 김영진, 백진기)이 5월 28일 발작성 야간 혈색소뇨증(Paroxysmal Nocturnal Hemoglobinuria, 이하 PNH) 치료제 엠파벨리주(pegcetacoplan)에 적용되는 인젝터의 첫 투약을 기준으로 국내 공급을 시.</p><p class="og-host">www.yakup.com</p></div></a></div><p> </p>
<!-- -->
